Martin Haberey
- Co-authors
- Karl‐Heinz ThierauchAndy M. ScuttKelly DobsonHolger Hess‐StumppFranziska HesselMichaël BaumannDaniel ZipsAndrew Scutt
- Topics
- Angiogenesis and VEGF in Cancer (7 papers)Cancer, Hypoxia, and Metabolism (3 papers)Lymphatic System and Diseases (3 papers)
- Cited by
- Cancer ResearchOncologyGenetics
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Martin Haberey
20 papers receiving 678 citations
Peers
Comparison fields: 5 of 89
- Molecular Biology 362
- Oncology 226
- Cancer Research 134
- Organic Chemistry 88
- Genetics 76
Countries citing papers authored by Martin Haberey
This map shows the geographic impact of Martin Haberey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Haberey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Haberey more than expected).
Fields of papers citing papers by Martin Haberey
This network shows the impact of papers produced by Martin Haberey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Haberey. The network helps show where Martin Haberey may publish in the future.
Co-authorship network of co-authors of Martin Haberey
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Haberey. A scholar is included among the top collaborators of Martin Haberey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Haberey. Martin Haberey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | ZK 261991. a novel VEGFR inhibitor for tumor therapy | 1 |
| 2 | 36 | |
| 3 | Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. | 75 |
| 4 | 55 | |
| 5 | 47 | |
| 6 | Experimental study on different combination schedules of VEGF-receptor inhibitor PTK787/ZK222584 and fractionated irradiation. | 44 |
| 7 | 1 | |
| 8 | 83 | |
| 9 | 14 | |
| 10 | 145 | |
| 11 | 67 | |
| 12 | 10 | |
| 13 | Effect of Na/K-ATPase inhibition on transmurally stimulated vascular contractions. | 3 |
| 14 | Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists. | 24 |
| 15 | 63 | |
| 16 | 1 | |
| 17 | Cardiovascular effects of iohexol in the rat and the isolated rabbit heart. | 8 |
| 18 | [In vivo-demonstration of cytoplasmic actomyosin-fibrils (author's transl)]. | 4 |
| 19 | 14 | |
| 20 | [Locomotion and substrate contact in Amoeba proteus]. | 9 |
About Martin Haberey
Martin Haberey is a scholar working on Oncology, Developmental Neuroscience and Orthopedics and Sports Medicine, having authored 22 papers that have together received 707 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (7 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Lymphatic System and Diseases (3 papers). The work is most often cited by research in Cancer Research (134 citations), Oncology (226 citations) and Genetics (76 citations). Martin Haberey has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Karl‐Heinz Thierauch, Andy M. Scutt, Kelly Dobson, Holger Hess‐Stumpp, Franziska Hessel, Michaël Baumann, Daniel Zips, Andrew Scutt, Dengshun Miao and Reinhold G. Erben. Their work appears in journals such as Cancer Research, Endocrinology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.